BioWorld MedTech

April 15, 2010

Heart valve device makers face hurdles in FDA process

It's no secret that getting a device through the FDA approval process can be time consuming, expensive, and — let's face it — downright difficult. (Medical Device Daily) Read More

Headset allows anesthesiologists to stay focused on the patients

Report from Europe: ConforMIS gets CE mark for new knee replacement system

Washington roundup: GE, Virginia Tech win patent for new CT angio technology

Financings roundup: Articulinx closes on 'B' $10M; Exact prices public offering

Today's MDD food for med-tech thought

Deals roundup: U.S. Renal care to acquire DCA for $112 million in cash

Court report: OrbusNeich claims stent tech misuse by Boston Scientific

Agreements/contracts: Hunt Bioscience to collaborate with Scotland's Tissue Solutions

Med-Tech Notes

Grants roundup: Muve awarded $835K from HHS for its Gruve device

Patent Watch: Interventional Spine gets U.S. patents for PDS system

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 14, 2025.

European VCs optimistic for med-tech exit opportunities in 2025

BioWorld MedTech

To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for February 14, 2025

European VCs bullish on med-tech investments in 2025

BioWorld MedTech

European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...

3D illustration of acute myeloid leukemia cells

Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML

BioWorld

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...